PERSPECTA

News from every angle

← Back to headlines

OneSource Specialty Pharma Bets on GLP-1 Drug Market Growth

OneSource Specialty Pharma is making a capacity-led investment, positioning itself to capitalize on the growing market for GLP-1 drugs.

9 May, 02:00 — 9 May, 02:00
PostShare

Sources

Showing 1 of 1 sources
indian-expressMostly Factual2h ago

OneSource Specialty Pharma: A capacity-led bet on the GLP-1 gold rush

By Rahul Rao

Read full article →

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

just now

Negros Power Implements 3-Month Freeze on Disconnections

just now

Mom, mama, nanay: The heroes that save homes when economic crisis hits

just now

NBI arrests five over unfair competition and misuse of La Union grape brand

just now